정책동향
Pharmaceutical Industry R&D for Diseases of the Developing World November 2011 (IFPMA Status Report)
- 등록일2012-10-12
- 조회수7977
- 분류정책동향 > 기타 > 기타
-
자료발간일
2011-11-15
-
출처
efpia
-
원문링크
-
키워드
#Pharmaceutical Industry R&D
- 첨부파일
Pharmaceutical Industry R&D for Diseases of the Developing World
November 2011 (IFPMA Status Report)
This document lists research-based pharmaceutical company(1) projects(2) to develop new medicines and vaccines for the ten diseases of the developing world (DDW) prioritized by the Programme for Research and Training in Tropical Diseases (TDR), co-sponsored by the UNICEF, the UNDP, the World Bank and the WHO. The diseases are, in order of decreasing mortality: tuberculosis, malaria, human African trypanosomiasis (sleeping sickness), leishmaniasis, dengue, onchocerciasis (River blindness), American trypanosomiasis (Chagas disease), schistosomiasis, leprosy and lymphatic filariasis. Data on projects published in 2005 by the Pharmaceutical R&D Policy Project (3) under Dr. Mary Moran, George Institute, and subsequently by the IFPMA show the evolution and status of industry R&D for DDW.
....(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.